<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Session 3: From Atlassing to therapy</title><style>
/* cspell:disable-file */
/* webkit printing magic: print all background colors */
html {
	-webkit-print-color-adjust: exact;
}
* {
	box-sizing: border-box;
	-webkit-print-color-adjust: exact;
}

html,
body {
	margin: 0;
	padding: 0;
}
@media only screen {
	body {
		margin: 2em auto;
		max-width: 900px;
		color: rgb(55, 53, 47);
	}
}

body {
	line-height: 1.5;
	white-space: pre-wrap;
}

a,
a.visited {
	color: inherit;
	text-decoration: underline;
}

.pdf-relative-link-path {
	font-size: 80%;
	color: #444;
}

h1,
h2,
h3 {
	letter-spacing: -0.01em;
	line-height: 1.2;
	font-weight: 600;
	margin-bottom: 0;
}

.page-title {
	font-size: 2.5rem;
	font-weight: 700;
	margin-top: 0;
	margin-bottom: 0.75em;
}

h1 {
	font-size: 1.875rem;
	margin-top: 1.875rem;
}

h2 {
	font-size: 1.5rem;
	margin-top: 1.5rem;
}

h3 {
	font-size: 1.25rem;
	margin-top: 1.25rem;
}

.source {
	border: 1px solid #ddd;
	border-radius: 3px;
	padding: 1.5em;
	word-break: break-all;
}

.callout {
	border-radius: 3px;
	padding: 1rem;
}

figure {
	margin: 1.25em 0;
	page-break-inside: avoid;
}

figcaption {
	opacity: 0.5;
	font-size: 85%;
	margin-top: 0.5em;
}

mark {
	background-color: transparent;
}

.indented {
	padding-left: 1.5em;
}

hr {
	background: transparent;
	display: block;
	width: 100%;
	height: 1px;
	visibility: visible;
	border: none;
	border-bottom: 1px solid rgba(55, 53, 47, 0.09);
}

img {
	max-width: 100%;
}

@media only print {
	img {
		max-height: 100vh;
		object-fit: contain;
	}
}

@page {
	margin: 1in;
}

.collection-content {
	font-size: 0.875rem;
}

.column-list {
	display: flex;
	justify-content: space-between;
}

.column {
	padding: 0 1em;
}

.column:first-child {
	padding-left: 0;
}

.column:last-child {
	padding-right: 0;
}

.table_of_contents-item {
	display: block;
	font-size: 0.875rem;
	line-height: 1.3;
	padding: 0.125rem;
}

.table_of_contents-indent-1 {
	margin-left: 1.5rem;
}

.table_of_contents-indent-2 {
	margin-left: 3rem;
}

.table_of_contents-indent-3 {
	margin-left: 4.5rem;
}

.table_of_contents-link {
	text-decoration: none;
	opacity: 0.7;
	border-bottom: 1px solid rgba(55, 53, 47, 0.18);
}

table,
th,
td {
	border: 1px solid rgba(55, 53, 47, 0.09);
	border-collapse: collapse;
}

table {
	border-left: none;
	border-right: none;
}

th,
td {
	font-weight: normal;
	padding: 0.25em 0.5em;
	line-height: 1.5;
	min-height: 1.5em;
	text-align: left;
}

th {
	color: rgba(55, 53, 47, 0.6);
}

ol,
ul {
	margin: 0;
	margin-block-start: 0.6em;
	margin-block-end: 0.6em;
}

li > ol:first-child,
li > ul:first-child {
	margin-block-start: 0.6em;
}

ul > li {
	list-style: disc;
}

ul.to-do-list {
	padding-inline-start: 0;
}

ul.to-do-list > li {
	list-style: none;
}

.to-do-children-checked {
	text-decoration: line-through;
	opacity: 0.375;
}

ul.toggle > li {
	list-style: none;
}

ul {
	padding-inline-start: 1.7em;
}

ul > li {
	padding-left: 0.1em;
}

ol {
	padding-inline-start: 1.6em;
}

ol > li {
	padding-left: 0.2em;
}

.mono ol {
	padding-inline-start: 2em;
}

.mono ol > li {
	text-indent: -0.4em;
}

.toggle {
	padding-inline-start: 0em;
	list-style-type: none;
}

/* Indent toggle children */
.toggle > li > details {
	padding-left: 1.7em;
}

.toggle > li > details > summary {
	margin-left: -1.1em;
}

.selected-value {
	display: inline-block;
	padding: 0 0.5em;
	background: rgba(206, 205, 202, 0.5);
	border-radius: 3px;
	margin-right: 0.5em;
	margin-top: 0.3em;
	margin-bottom: 0.3em;
	white-space: nowrap;
}

.collection-title {
	display: inline-block;
	margin-right: 1em;
}

.page-description {
    margin-bottom: 2em;
}

.simple-table {
	margin-top: 1em;
	font-size: 0.875rem;
	empty-cells: show;
}
.simple-table td {
	height: 29px;
	min-width: 120px;
}

.simple-table th {
	height: 29px;
	min-width: 120px;
}

.simple-table-header-color {
	background: rgb(247, 246, 243);
	color: black;
}
.simple-table-header {
	font-weight: 500;
}

time {
	opacity: 0.5;
}

.icon {
	display: inline-block;
	max-width: 1.2em;
	max-height: 1.2em;
	text-decoration: none;
	vertical-align: text-bottom;
	margin-right: 0.5em;
}

img.icon {
	border-radius: 3px;
}

.user-icon {
	width: 1.5em;
	height: 1.5em;
	border-radius: 100%;
	margin-right: 0.5rem;
}

.user-icon-inner {
	font-size: 0.8em;
}

.text-icon {
	border: 1px solid #000;
	text-align: center;
}

.page-cover-image {
	display: block;
	object-fit: cover;
	width: 100%;
	max-height: 30vh;
}

.page-header-icon {
	font-size: 3rem;
	margin-bottom: 1rem;
}

.page-header-icon-with-cover {
	margin-top: -0.72em;
	margin-left: 0.07em;
}

.page-header-icon img {
	border-radius: 3px;
}

.link-to-page {
	margin: 1em 0;
	padding: 0;
	border: none;
	font-weight: 500;
}

p > .user {
	opacity: 0.5;
}

td > .user,
td > time {
	white-space: nowrap;
}

input[type="checkbox"] {
	transform: scale(1.5);
	margin-right: 0.6em;
	vertical-align: middle;
}

p {
	margin-top: 0.5em;
	margin-bottom: 0.5em;
}

.image {
	border: none;
	margin: 1.5em 0;
	padding: 0;
	border-radius: 0;
	text-align: center;
}

.code,
code {
	background: rgba(135, 131, 120, 0.15);
	border-radius: 3px;
	padding: 0.2em 0.4em;
	border-radius: 3px;
	font-size: 85%;
	tab-size: 2;
}

code {
	color: #eb5757;
}

.code {
	padding: 1.5em 1em;
}

.code-wrap {
	white-space: pre-wrap;
	word-break: break-all;
}

.code > code {
	background: none;
	padding: 0;
	font-size: 100%;
	color: inherit;
}

blockquote {
	font-size: 1.25em;
	margin: 1em 0;
	padding-left: 1em;
	border-left: 3px solid rgb(55, 53, 47);
}

.bookmark {
	text-decoration: none;
	max-height: 8em;
	padding: 0;
	display: flex;
	width: 100%;
	align-items: stretch;
}

.bookmark-title {
	font-size: 0.85em;
	overflow: hidden;
	text-overflow: ellipsis;
	height: 1.75em;
	white-space: nowrap;
}

.bookmark-text {
	display: flex;
	flex-direction: column;
}

.bookmark-info {
	flex: 4 1 180px;
	padding: 12px 14px 14px;
	display: flex;
	flex-direction: column;
	justify-content: space-between;
}

.bookmark-image {
	width: 33%;
	flex: 1 1 180px;
	display: block;
	position: relative;
	object-fit: cover;
	border-radius: 1px;
}

.bookmark-description {
	color: rgba(55, 53, 47, 0.6);
	font-size: 0.75em;
	overflow: hidden;
	max-height: 4.5em;
	word-break: break-word;
}

.bookmark-href {
	font-size: 0.75em;
	margin-top: 0.25em;
}

.sans { font-family: ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol"; }
.code { font-family: "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace; }
.serif { font-family: Lyon-Text, Georgia, ui-serif, serif; }
.mono { font-family: iawriter-mono, Nitti, Menlo, Courier, monospace; }
.pdf .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK JP'; }
.pdf:lang(zh-CN) .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK SC'; }
.pdf:lang(zh-TW) .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK TC'; }
.pdf:lang(ko-KR) .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK KR'; }
.pdf .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK JP'; }
.pdf:lang(zh-CN) .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK SC'; }
.pdf:lang(zh-TW) .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK TC'; }
.pdf:lang(ko-KR) .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK KR'; }
.pdf .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK JP'; }
.pdf:lang(zh-CN) .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK SC'; }
.pdf:lang(zh-TW) .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK TC'; }
.pdf:lang(ko-KR) .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK KR'; }
.pdf .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK JP'; }
.pdf:lang(zh-CN) .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK SC'; }
.pdf:lang(zh-TW) .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK TC'; }
.pdf:lang(ko-KR) .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK KR'; }
.highlight-default {
	color: rgba(55, 53, 47, 1);
}
.highlight-gray {
	color: rgba(120, 119, 116, 1);
	fill: rgba(120, 119, 116, 1);
}
.highlight-brown {
	color: rgba(159, 107, 83, 1);
	fill: rgba(159, 107, 83, 1);
}
.highlight-orange {
	color: rgba(217, 115, 13, 1);
	fill: rgba(217, 115, 13, 1);
}
.highlight-yellow {
	color: rgba(203, 145, 47, 1);
	fill: rgba(203, 145, 47, 1);
}
.highlight-teal {
	color: rgba(68, 131, 97, 1);
	fill: rgba(68, 131, 97, 1);
}
.highlight-blue {
	color: rgba(51, 126, 169, 1);
	fill: rgba(51, 126, 169, 1);
}
.highlight-purple {
	color: rgba(144, 101, 176, 1);
	fill: rgba(144, 101, 176, 1);
}
.highlight-pink {
	color: rgba(193, 76, 138, 1);
	fill: rgba(193, 76, 138, 1);
}
.highlight-red {
	color: rgba(212, 76, 71, 1);
	fill: rgba(212, 76, 71, 1);
}
.highlight-default_background {
	color: rgba(55, 53, 47, 1);
}
.highlight-gray_background {
	background: rgba(241, 241, 239, 1);
}
.highlight-brown_background {
	background: rgba(244, 238, 238, 1);
}
.highlight-orange_background {
	background: rgba(251, 236, 221, 1);
}
.highlight-yellow_background {
	background: rgba(251, 243, 219, 1);
}
.highlight-teal_background {
	background: rgba(237, 243, 236, 1);
}
.highlight-blue_background {
	background: rgba(231, 243, 248, 1);
}
.highlight-purple_background {
	background: rgba(244, 240, 247, 0.8);
}
.highlight-pink_background {
	background: rgba(249, 238, 243, 0.8);
}
.highlight-red_background {
	background: rgba(253, 235, 236, 1);
}
.block-color-default {
	color: inherit;
	fill: inherit;
}
.block-color-gray {
	color: rgba(120, 119, 116, 1);
	fill: rgba(120, 119, 116, 1);
}
.block-color-brown {
	color: rgba(159, 107, 83, 1);
	fill: rgba(159, 107, 83, 1);
}
.block-color-orange {
	color: rgba(217, 115, 13, 1);
	fill: rgba(217, 115, 13, 1);
}
.block-color-yellow {
	color: rgba(203, 145, 47, 1);
	fill: rgba(203, 145, 47, 1);
}
.block-color-teal {
	color: rgba(68, 131, 97, 1);
	fill: rgba(68, 131, 97, 1);
}
.block-color-blue {
	color: rgba(51, 126, 169, 1);
	fill: rgba(51, 126, 169, 1);
}
.block-color-purple {
	color: rgba(144, 101, 176, 1);
	fill: rgba(144, 101, 176, 1);
}
.block-color-pink {
	color: rgba(193, 76, 138, 1);
	fill: rgba(193, 76, 138, 1);
}
.block-color-red {
	color: rgba(212, 76, 71, 1);
	fill: rgba(212, 76, 71, 1);
}
.block-color-default_background {
	color: inherit;
	fill: inherit;
}
.block-color-gray_background {
	background: rgba(241, 241, 239, 1);
}
.block-color-brown_background {
	background: rgba(244, 238, 238, 1);
}
.block-color-orange_background {
	background: rgba(251, 236, 221, 1);
}
.block-color-yellow_background {
	background: rgba(251, 243, 219, 1);
}
.block-color-teal_background {
	background: rgba(237, 243, 236, 1);
}
.block-color-blue_background {
	background: rgba(231, 243, 248, 1);
}
.block-color-purple_background {
	background: rgba(244, 240, 247, 0.8);
}
.block-color-pink_background {
	background: rgba(249, 238, 243, 0.8);
}
.block-color-red_background {
	background: rgba(253, 235, 236, 1);
}
.select-value-color-uiBlue { background-color: rgba(35, 131, 226, .07); }
.select-value-color-pink { background-color: rgba(245, 224, 233, 1); }
.select-value-color-purple { background-color: rgba(232, 222, 238, 1); }
.select-value-color-green { background-color: rgba(219, 237, 219, 1); }
.select-value-color-gray { background-color: rgba(227, 226, 224, 1); }
.select-value-color-transparentGray { background-color: rgba(227, 226, 224, 0); }
.select-value-color-translucentGray { background-color: rgba(0, 0, 0, 0.06); }
.select-value-color-orange { background-color: rgba(250, 222, 201, 1); }
.select-value-color-brown { background-color: rgba(238, 224, 218, 1); }
.select-value-color-red { background-color: rgba(255, 226, 221, 1); }
.select-value-color-yellow { background-color: rgba(253, 236, 200, 1); }
.select-value-color-blue { background-color: rgba(211, 229, 239, 1); }
.select-value-color-pageGlass { background-color: undefined; }
.select-value-color-washGlass { background-color: undefined; }

.checkbox {
	display: inline-flex;
	vertical-align: text-bottom;
	width: 16;
	height: 16;
	background-size: 16px;
	margin-left: 2px;
	margin-right: 5px;
}

.checkbox-on {
	background-image: url("data:image/svg+xml;charset=UTF-8,%3Csvg%20width%3D%2216%22%20height%3D%2216%22%20viewBox%3D%220%200%2016%2016%22%20fill%3D%22none%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%0A%3Crect%20width%3D%2216%22%20height%3D%2216%22%20fill%3D%22%2358A9D7%22%2F%3E%0A%3Cpath%20d%3D%22M6.71429%2012.2852L14%204.9995L12.7143%203.71436L6.71429%209.71378L3.28571%206.2831L2%207.57092L6.71429%2012.2852Z%22%20fill%3D%22white%22%2F%3E%0A%3C%2Fsvg%3E");
}

.checkbox-off {
	background-image: url("data:image/svg+xml;charset=UTF-8,%3Csvg%20width%3D%2216%22%20height%3D%2216%22%20viewBox%3D%220%200%2016%2016%22%20fill%3D%22none%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%0A%3Crect%20x%3D%220.75%22%20y%3D%220.75%22%20width%3D%2214.5%22%20height%3D%2214.5%22%20fill%3D%22white%22%20stroke%3D%22%2336352F%22%20stroke-width%3D%221.5%22%2F%3E%0A%3C%2Fsvg%3E");
}
	
</style></head><body><article id="13a2e869-bf9d-801b-8f90-fc1e987c46e7" class="page sans"><header><h1 class="page-title">Session 3: From Atlassing to therapy</h1><p class="page-description"></p></header><div class="page-body"><nav id="1422e869-bf9d-80a1-89c1-c7fa3af1f41b" class="block-color-gray table_of_contents"><div class="table_of_contents-item table_of_contents-indent-0"><a class="table_of_contents-link" href="#1422e869-bf9d-8073-b8b7-c574b83302c2">1) Characterizing Diverse Cell Types in the Developing Human Brain and Brain Cancer</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-803d-8b7b-edbb72b45442">Topic 1: Developing and adult brain meta-atlas</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-80e0-8a0f-e7ac2a8f0315">Topic 2: Glioblastoma</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-8095-8b5a-dd24d2561b0b">QnA</a></div><div class="table_of_contents-item table_of_contents-indent-0"><a class="table_of_contents-link" href="#1422e869-bf9d-800f-a5c6-efd6c46aa253">2) Neuron-glial interactions in brain health and disease</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-80d9-9859-d56edccbbe38">Topic 1: Glioma â†’ spatialomeproally patterns &amp; myelination</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-8082-8e97-e5e248c6ee88">QnA</a></div><div class="table_of_contents-item table_of_contents-indent-0"><a class="table_of_contents-link" href="#1422e869-bf9d-8065-a62c-c6901aa6b8ed">3) Enhancer-AAVs enable circuit access across species and circuit selective therapies</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-806a-9259-e5e7cde47bea">Topic 1: Cell type / Region specific enhancer-AAV targeting</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-8036-a70d-dfd34b0eeefd">Topic 2: Disease-context application</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-80a5-976f-ee6888222fbe">QnA.</a></div><div class="table_of_contents-item table_of_contents-indent-0"><a class="table_of_contents-link" href="#1422e869-bf9d-80d1-976c-ee2b7f9fa4aa">4) Spatially resolved single-cell genomics &amp; cell atlas of the brain</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-803f-9120-c3fe3ae5429e">Cell type specific 3D genome genome organization (<a href="https://www.biorxiv.org/content/10.1101/2023.12.04.570024v1">Liu et al., bioRxiv 2023</a>)</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-80cb-bef7-c6e359a4293d">QnA</a></div><div class="table_of_contents-item table_of_contents-indent-0"><a class="table_of_contents-link" href="#1422e869-bf9d-8070-99ab-c5c4af33a4db">5) Modeling and repairing the human brain with stem cells</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-80ba-a491-fbd929743b17">Developing cell therapy for Parkinsonâ€™s disease</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-8089-a83f-f4461f11805f">Where are we now with hPSC-based trials?</a></div><div class="table_of_contents-item table_of_contents-indent-1"><a class="table_of_contents-link" href="#1422e869-bf9d-808a-97d1-db5f3fe72e9c">QnA</a></div><div class="table_of_contents-item table_of_contents-indent-0"><a class="table_of_contents-link" href="#1422e869-bf9d-805c-8fef-e1c02b017fd2">Selected poster: TREM2-dependence of Microglial Activation in Alzheimer&#x27;s Disease</a></div></nav><h2 id="1422e869-bf9d-8073-b8b7-c574b83302c2" class="">1) Characterizing Diverse Cell Types in the Developing Human Brain and Brain Cancer</h2><p id="1422e869-bf9d-80a4-b55f-da445e06abff" class=""><strong><a href="https://www.vibconferences.be/speaker/aparna-bhaduri">Aparna Bhaduri</a></strong><strong> </strong>- <em>University of California, Los Angeles (UCLA), US</em></p><figure class="block-color-orange_background callout" style="white-space:pre-wrap;display:flex" id="1422e869-bf9d-800a-baf0-c546ed01dd93"><div style="font-size:1.5em"><span class="icon">ğŸ’¡</span></div><div style="width:100%"><p id="1422e869-bf9d-81d5-8969-cae6841dbfd8" class="">maturation</p><p id="1422e869-bf9d-81be-9ac7-e0d917abba21" class="">read number</p></div></figure><h3 id="1422e869-bf9d-803d-8b7b-edbb72b45442" class="">Topic 1: Developing and adult brain meta-atlas</h3><p id="1422e869-bf9d-80ea-afe7-dbfe336d8106" class="">[Developing Brain ê³¼ adult brainì€ í° ì°¨ì´ê°€ ìˆìŒ]</p><ul id="1422e869-bf9d-80f1-9a7e-d7587b0299ed" class="bulleted-list"><li style="list-style-type:disc">transient cell types </li></ul><ul id="1422e869-bf9d-80a3-9c9b-edb2267a63f2" class="bulleted-list"><li style="list-style-type:disc">Cortical development<ul id="1422e869-bf9d-811d-a3d7-e64da1133374" class="bulleted-list"><li style="list-style-type:circle">Outer radial glia</li></ul><ul id="1422e869-bf9d-810d-ae4e-d8097dbc1b4e" class="bulleted-list"><li style="list-style-type:circle">neurogenesis ëë‚œ ë‹¤ìŒì— gliogenesisê°€ ì‹œì‘ë¨ <ul id="1422e869-bf9d-8083-bfa2-e4e0600ac79d" class="bulleted-list"><li style="list-style-type:square"><strong>Human susceptibilityë¥¼ ì—°êµ¬í•˜ë ¤ë©´ ê²°êµ­ human vs. mouse ì°¨ì´ì— í¬ì»¤ìŠ¤ í•„ìš”.</strong></li></ul></li></ul><figure id="1422e869-bf9d-80e6-953f-ca27351ffe4a" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image.png"><img style="width:617.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image.png"/></a></figure></li></ul><ul id="1422e869-bf9d-8057-9c2e-d49d7a25e7a4" class="bulleted-list"><li style="list-style-type:disc">Developmental atlas<figure id="1422e869-bf9d-802b-8d4c-d4822162a876" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%201.png"><img style="width:617.984375px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%201.png"/></a></figure><ul id="1422e869-bf9d-81f6-8fb1-d644fda9cf3c" class="bulleted-list"><li style="list-style-type:circle">pulbic data</li></ul><ul id="1422e869-bf9d-81bb-8923-fbb06129a0a4" class="bulleted-list"><li style="list-style-type:circle">comparison in in vitro </li></ul></li></ul><ul id="1422e869-bf9d-80e2-851c-df59b644deaf" class="bulleted-list"><li style="list-style-type:disc">ì˜¤ëŠ˜ì˜ ì£¼ì œ<figure id="1422e869-bf9d-80d9-929c-ed2fd9a9fede" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%202.png"><img style="width:617.9765625px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%202.png"/></a></figure><ul id="1422e869-bf9d-8103-aa0b-d31dde94f426" class="bulleted-list"><li style="list-style-type:circle">How do human neural stem cells build human brain</li></ul><ul id="1422e869-bf9d-8172-8ed1-d1822f608d9f" class="bulleted-list"><li style="list-style-type:circle">Why are they devastating in brain cancer</li></ul></li></ul><ul id="1422e869-bf9d-800c-ac2b-fd8856d80eb6" class="bulleted-list"><li style="list-style-type:disc">github) <a href="https://github.com/BhaduriLab/dev-ctx-meta-atlas">https://github.com/BhaduriLab/dev-ctx-meta-atlas</a></li></ul><ul id="1422e869-bf9d-80ee-90f2-dba6c61ae0a6" class="bulleted-list"><li style="list-style-type:disc">96 individual â†’ meta-atlas. Technical variationì„ ìµœì†Œí™”í•˜ëŠ” ë°©í–¥ìœ¼ë¡œ ë°ì´í„° êµ¬ì¶•í•˜ì˜€ìŒ.<ul id="1422e869-bf9d-803a-a278-dd03a210e732" class="bulleted-list"><li style="list-style-type:circle">7 dataset collapsed.</li></ul><ul id="1422e869-bf9d-8115-b44d-cc820304b690" class="bulleted-list"><li style="list-style-type:circle">unsupervised clusteirng of cells for each individuals</li></ul><ul id="1422e869-bf9d-81ec-89f8-fd0b73ff5cce" class="bulleted-list"><li style="list-style-type:circle">Identification of each of the modules within the individual </li></ul><ul id="1422e869-bf9d-81d1-ae5a-f534691e0084" class="bulleted-list"><li style="list-style-type:circle">cell type specificê³¼ broad ëª¨ë‘ ë‚˜íƒ€ë‚¨</li></ul></li></ul><ul id="1422e869-bf9d-80cc-930f-e06421d76006" class="bulleted-list"><li style="list-style-type:disc">Identification gene expression signature within each individuals â†’ integrate meta-module?<figure id="1422e869-bf9d-8012-8b2c-dc7531259513" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%203.png"><img style="width:617.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%203.png"/></a></figure><ul id="1422e869-bf9d-806a-92c3-ef4c6e0e09d2" class="bulleted-list"><li style="list-style-type:circle">Gene expression signatureë¥¼ í™•ì¸ â†’ ê°ê° clusterë§ˆë‹¤. ê·¸ë¦¬ê³  moduleí™”í•˜ì˜€ë‹¤.</li></ul><ul id="1422e869-bf9d-817b-b649-c5d967f906bd" class="bulleted-list"><li style="list-style-type:circle">Meta-module â†’ gene netwroks ë¹„ìŠ·í•˜ê²Œ ê¸°ëŠ¥ì ìœ¼ë¡œ ì—°ê´€ëœ ìœ ì „ìë“¤ì˜ ì§‘í•©ì¸ê°€</li></ul><ul id="1422e869-bf9d-81f8-a04b-d5d681626012" class="bulleted-list"><li style="list-style-type:circle">Gene expression signatureë¼ëŠ” ê²ƒì´ ë¬´ì—‡ì¼ê¹Œ â†’ ìš°ë¦¬ atlas ë¶„ì„ì—ì„œë„ ì´ê±¸ í™œìš© ê°€ëŠ¥?</li></ul></li></ul><ul id="1422e869-bf9d-803f-9d11-c823bb9a37a7" class="bulleted-list"><li style="list-style-type:disc">ì´í›„ ë¶„ì„ â†’ meta-moduleì„ ê°€ì§€ê³  cell type specificity ë“±ì„ scoringí•˜ì—¬ ë¹„êµ<ul id="1422e869-bf9d-81e3-aa10-cc0099bbebf7" class="bulleted-list"><li style="list-style-type:circle">Adult vs developmental module ë§Œë“¤ê³ ì í•¨<ul id="1422e869-bf9d-8106-87c5-cffa5dde168d" class="bulleted-list"><li style="list-style-type:square">adult atlasë„ ë§Œë“¦ â†’ ê·¸ ë‹¤ìŒì— module ë§Œë“¦</li></ul><ul id="1422e869-bf9d-81eb-9f14-e540e5d7ddee" class="bulleted-list"><li style="list-style-type:square">adultì™€ developmental moduleì´ ë‹¤ë¦„ </li></ul></li></ul><ul id="1422e869-bf9d-81ce-9dfa-d4e5a3ac785e" class="bulleted-list"><li style="list-style-type:circle">Developmental cell typesë“¤ì´ adult ë³´ë‹¤ ë” cell type variationì´ ì»¸ë‹¤?</li></ul><ul id="1422e869-bf9d-81c4-ab7a-dfd3cfedeaa5" class="bulleted-list"><li style="list-style-type:circle">ì§ˆë¬¸) ì—¬ê¸°ì„œ ëª¨ë“ˆì´ ì–´ë–»ê²Œ êµ¬ì¶•ëœê²ƒì¼ê¹Œ? WGCNAê°™ì€ ì ‘ê·¼ìœ¼ë¡œ?</li></ul><ul id="1422e869-bf9d-81e4-a822-ecd579ff8910" class="bulleted-list"><li style="list-style-type:circle">êµ¬ì²´ì ì¸ ë¶„ì„: Module 20 and FEZF2<ul id="1422e869-bf9d-81b9-8ab6-f2fcf88b92b8" class="bulleted-list"><li style="list-style-type:square">FEZF2 in deep layer neurons </li></ul><ul id="1422e869-bf9d-8182-8f17-fe42f7b445ef" class="bulleted-list"><li style="list-style-type:square">ë¬¸í—Œì¡°ì‚¬, ê·¸ë¦¬ê³  activity levelì„ ì´ìš©í•˜ì—¬ FEZF2ê°€ ë‹¤ë¥¸ autism ìœ ì „ìë“¤ì„ ì¡°ì ˆí•  ê²ƒì´ë¼ê³  ìƒê°í•¨</li></ul><ul id="1422e869-bf9d-81c9-8a31-d95ce273806f" class="bulleted-list"><li style="list-style-type:square">timingê³¼ evolutionì— í° ì˜í–¥ì„ ì¤„ ê²ƒìœ¼ë¡œ ìƒê°ì´ ë˜ë©°, </li></ul><ul id="1422e869-bf9d-8160-96c1-e424285fdb30" class="bulleted-list"><li style="list-style-type:square">TSZH3ì—ë„ í° ì˜í–¥ì„ ì¤„ ê²ƒì´ë‹¤.</li></ul><figure id="1422e869-bf9d-8067-a1df-fbb7c8413c91" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%204.png"><img style="width:589.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%204.png"/></a></figure></li></ul></li></ul><ul id="1422e869-bf9d-8001-8bfd-fb8f0d316f5b" class="bulleted-list"><li style="list-style-type:disc">FEZF2 â†’ mouse vs. human ë‹¤ë¥´ê³ , timingì´ evolutionì— í° ì˜í–¥ ë¯¸ì¹˜ëŠ” ìœ ì „ìë¡œ ìƒê°ë¨.</li></ul><ul id="1422e869-bf9d-804c-b035-f0a462b7fddf" class="bulleted-list"><li style="list-style-type:disc">shRNA perturbation â†’ hairpin ê°ì—¼ì‹œì¼œì„œ ê°ì—¼ëœ cellë“¤ì„ sort outí•´ì„œ ë¶„ì„.</li></ul><ul id="1422e869-bf9d-80fd-b138-d446dadf2489" class="bulleted-list"><li style="list-style-type:disc">FEZF2 â†’ TSZH3ì˜ epxressionìœ¼ë¡œ immature neruonì´ deep layer neurondìœ¼ë¡œ maturation<ul id="1422e869-bf9d-8124-9250-c3c9bb3d08f0" class="bulleted-list"><li style="list-style-type:circle">Chromatin accessibility<ul id="1422e869-bf9d-815a-ba84-ed8156769478" class="bulleted-list"><li style="list-style-type:square">FEZF2ëŠ”  activity ì—†ìŒ</li></ul><ul id="1422e869-bf9d-8192-b8f6-c3d30bbfbea1" class="bulleted-list"><li style="list-style-type:square">TSZH3 ì€ ë§¤ìš° í¼</li></ul><ul id="1422e869-bf9d-8152-99d5-dbc178ec69f4" class="bulleted-list"><li style="list-style-type:square">ë”°ë¼ì„œ ì—­í• ì´ ë‹¤ë¥´ë‹¤ê³  í•¨ + ìˆœì„œ</li></ul></li></ul><ul id="1422e869-bf9d-8139-a7f0-cd84ec1b911a" class="bulleted-list"><li style="list-style-type:circle">TSZH3ëŠ” FEZF2ì˜ chromatin accessibilityê°€ í•„ìš”í–ˆë˜ ê²ƒìœ¼ë¡œ ë³´ì•„ FEZF2ê°€ TSZH3ë¥¼ activation?</li></ul><ul id="1422e869-bf9d-8029-98a8-cfac4e70863d" class="bulleted-list"><li style="list-style-type:circle"><a href="https://github.com/BhaduriLab/dev-ctx-meta-atlas">https://github.com/BhaduriLab/dev-ctx-meta-atlas</a></li></ul></li></ul><h3 id="1422e869-bf9d-80e0-8a0f-e7ac2a8f0315" class="">Topic 2: Glioblastoma</h3><ul id="1422e869-bf9d-804f-87b1-f1791b98959f" class="bulleted-list"><li style="list-style-type:disc">ì•„ë§ˆë„ ì´ paper? â†’ <a href="https://www.biorxiv.org/content/10.1101/2024.07.24.604840v1.full">https://www.biorxiv.org/content/10.1101/2024.07.24.604840v1.full</a></li></ul><ul id="1422e869-bf9d-800c-9787-eca0236c9d0e" class="bulleted-list"><li style="list-style-type:disc">ë¶„ì„ ì „ëµ/ë°©ì‹ì€ meta-atlasì™€ ë¹„ìŠ·í•œê°€</li></ul><ul id="1422e869-bf9d-801f-821f-d74de1465a30" class="bulleted-list"><li style="list-style-type:disc">Neftelì˜ í˜ì´í¼ì™€ cell typeì´ ìœ ì‚¬í•¨</li></ul><ul id="1422e869-bf9d-8061-9880-d62cfb456113" class="bulleted-list"><li style="list-style-type:disc">Moduleì„ ì‚´í´ë³´ì•˜ì„ ë•Œ, 11ì´ ì•„ì£¼ vascularì— ë§¤ìš° êµ¬ì²´ì ì„<ul id="1422e869-bf9d-81d3-a525-e8ed4a3e5bfc" class="bulleted-list"><li style="list-style-type:circle">ì´ moduleì— ëŒ€í•´ì„œ ë” ì¡°ì‚¬í•˜ë ¤ê³  í•¨ vascularì— ì œí•œë˜ì§€ ì•Šì„ ê²ƒì´ë¼ëŠ” ìƒê°</li></ul></li></ul><ul id="1422e869-bf9d-8056-9eb5-c81f612c4a89" class="bulleted-list"><li style="list-style-type:disc">ì´ moduleì´ PDGFRAbeta ë¡œ ëŒ€í‘œì ì´ë¯€ë¡œ, ì´ê²ƒì„ ê¸°ì¤€ìœ¼ë¡œ í–‡ ã…“ì„¸í¬ë¥¼ ë‚˜ëˆ„ê³ , ê·¸ ì„¸í¬ë¥¼ scRNAí•¨.<ul id="1422e869-bf9d-814f-9974-c229e8b90928" class="bulleted-list"><li style="list-style-type:circle">ì´ë¥¼ í†µí•´ astro, OPC ë“±ì˜ ë‹¤ë¥¸ ê²ƒë“¤ì—ë„ expression ë˜ëŠ” ê²ƒì´ ë“œëŸ¬ë‚¨. </li></ul><p id="1422e869-bf9d-8150-9f2f-c987ac21c7b0" class="">â†’ Neurovascular progenitorê°€ ìˆë‹¤ê³  ìƒê°í•¨ </p><ul id="1422e869-bf9d-8120-8e86-fb97d1ac453d" class="bulleted-list"><li style="list-style-type:circle">GBMì—ì„œ pericyte ì œê±°í•  ê²½ìš° â†’ GBM tumorê°€ shrink.</li></ul><ul id="1422e869-bf9d-81c2-a11c-ebec8f8c89eb" class="bulleted-list"><li style="list-style-type:circle">Pericyteì™€ neuronì´ ì—°ê´€ì´ ìˆë‹¤ê³  ìƒê° </li></ul></li></ul><ul id="1422e869-bf9d-803c-b1fd-ec1b43a8f975" class="bulleted-list"><li style="list-style-type:disc">GBM scRNA-seq â†’ NVP population ë°œê²¬. ì´ë“¤ì„ KOí•˜ê³ ì.<ul id="1422e869-bf9d-8115-91be-e547c3883898" class="bulleted-list"><li style="list-style-type:circle">ì‹¤ì œ KO íš¨ê³¼ë¡œ population ë³€í™” ë°œìƒ, survival extend. </li></ul></li></ul><ul id="1422e869-bf9d-8013-aacc-e1b6bd10249e" class="bulleted-list"><li style="list-style-type:disc">CellTag â†’ DNA barcoding technique (Samantha Morris in WashU)</li></ul><ul id="1422e869-bf9d-8085-a1d9-cb3011639ca5" class="bulleted-list"><li style="list-style-type:disc">Human organoid tumor transplantation (HOTT)<ul id="1422e869-bf9d-81bc-8356-fd7c0828a383" class="bulleted-list"><li style="list-style-type:circle">Patient tumor, </li></ul></li></ul><h3 id="1422e869-bf9d-8095-8b5a-dd24d2561b0b" class="">QnA</h3><ul id="1422e869-bf9d-8038-a733-de5cd171f8cd" class="bulleted-list"><li style="list-style-type:disc">TSZH3 â†’ ì´ê±¸ KO organoidì—ì„œ ë‹¤ì‹œ ì‚´ë¦¬ë©´ ë‹¤ì‹œ layer 5ê°€ ìƒê¹€?<ul id="1422e869-bf9d-81f6-9724-c25c4dd11e97" class="bulleted-list"><li style="list-style-type:circle">ì•„ì£¼ ì¢‹ì€ ì§ˆë¬¸ì´ë‹¤. ê·¸ëŸ¬ë‚˜ ì•„ì§ ì‹¤í—˜ í•´ë³´ì§„ ì•ŠìŒ. ë…¼ë¦¬ì ìœ¼ë¡œ ë‹¤ìŒ ë‹¨ê³„ì—ì„œ í•´ì•¼ í•  ì‹¤í—˜ì´ë¼ê³  ìƒê°ë¨. </li></ul></li></ul><ul id="1422e869-bf9d-806b-84a5-c486c061cebd" class="bulleted-list"><li style="list-style-type:disc">Brain cancerì—ì„œ immunotherapyê°€ ê°€ì¥ ì¤‘ìš”í•œ ê²ƒ ê°™ì€ë°, ê·¸ê²ƒì— ëŒ€í•œ ì˜ê²¬ì€ ì–´ë–¤ê°€ <ul id="1422e869-bf9d-81b0-83ed-dce3a5035aba" class="bulleted-list"><li style="list-style-type:circle">immunotherapy tissueë¥¼ ì–»ëŠ” ì¤‘ì´ë‹¤. </li></ul><ul id="1422e869-bf9d-81ac-bc53-ffb15f526cac" class="bulleted-list"><li style="list-style-type:circle">ê·¼ë° ì´ ê²ƒì— ëŒ€í•´ì„œ ë‹¤ì–‘í•œ ë°©ì‹ìœ¼ë¡œ ì•”ì´ ë°˜ì‘ í•´ì„œ, ê·¸ê²ƒì„ cell type specificí•œ íŒ¨í„´ì„ ì‚´í´ë´ì•¼ í•œë‹¤ê³  ìƒê°í•˜ëŠ” ì¤‘ì´ë‹¤. </li></ul><p id="1422e869-bf9d-8152-b709-c1877dcbc23a" class="">
</p></li></ul><h2 id="1422e869-bf9d-800f-a5c6-efd6c46aa253" class="">2) Neuron-glial interactions in brain health and disease</h2><p id="1422e869-bf9d-802f-934e-c181b70afd4f" class=""><strong><a href="https://www.vibconferences.be/speaker/michelle-monje">Michelle Monje</a></strong><strong> - </strong><em>Stanford University &amp; Howard Hughes Medical Institute, US</em></p><p id="1422e869-bf9d-8065-828c-ff47a10b3697" class="">â†’ ì°¾ì•„ë³´ë‹ˆ Glioma ì—°êµ¬ì— ì§„ì‹¬ì´ì‹  ë“¯</p><h3 id="1422e869-bf9d-80d9-9859-d56edccbbe38" class="">Topic 1: Glioma â†’ spatialomeproally patterns &amp; myelination</h3><ul id="1422e869-bf9d-80e1-9983-ca02eea0a4b8" class="bulleted-list"><li style="list-style-type:disc">Gliomalignancy â†’ predictable spatiotemporal pattern.<ul id="1422e869-bf9d-8136-9d84-f24be5f93063" class="bulleted-list"><li style="list-style-type:circle">4 year oldì—ì„œëŠ” ëˆˆìª½ (optic glioma) â†’ 6 year old (pons), 10 year old (thalamus), 14 year old (hemispheric)ìœ¼ë¡œ ë°œì „<ul id="1422e869-bf9d-8136-8103-da17338b87a2" class="bulleted-list"><li style="list-style-type:square">4 year â†’ ìƒì¡´ì€ ê°€ëŠ¥í•˜ë‚˜ severe symptomì„ ë‚¨ê¹€ (blindness ë“±)</li></ul><ul id="1422e869-bf9d-812e-aaf8-fa73899262ef" class="bulleted-list"><li style="list-style-type:square">6 year â†’ infiltrate. nervous system ì „ì²´ì— í¼ì ¸ì„œ fatal.</li></ul></li></ul></li></ul><ul id="1422e869-bf9d-80d2-9af9-dd2764e055e2" class="bulleted-list"><li style="list-style-type:disc">Developmental processes?<ul id="1422e869-bf9d-81f1-8ecb-e5cfc1ee0180" class="bulleted-list"><li style="list-style-type:circle">Myelination â†’ 3rd trim.ë•Œë¶€í„° birth ì´í›„ postnatalë¶€í„° develop í™•ì¥</li></ul><ul id="1422e869-bf9d-81f4-b026-eed3a04b3730" class="bulleted-list"><li style="list-style-type:circle">intercortical ì˜ì—­ì€ childhoodë¶€í„° young adultê¹Œì§€</li></ul></li></ul><ul id="1422e869-bf9d-8081-b8fd-fcfac75c85ab" class="bulleted-list"><li style="list-style-type:disc">Childhood ë•Œ glioma â†’ myelination ì´ìƒ (pons, )<ul id="1422e869-bf9d-815f-bdfe-c071b78b58ef" class="bulleted-list"><li style="list-style-type:circle">Glioma myelintaion â†’ opc ìƒíƒœì™€ ìœ ì‚¬</li></ul></li></ul><ul id="1422e869-bf9d-805c-8af7-c3b6c0b8cb2e" class="bulleted-list"><li style="list-style-type:disc">Main question. OPCì˜ proliferationì„ ì¼ìœ¼í‚¤ëŠ” ê²ƒì€ ë¬´ì—‡ì¸ê°€? Neuronì´ ì˜í–¥ë¯¸ì¹˜ë‚˜?<ul id="1422e869-bf9d-81bc-a3f5-ede85d511d7b" class="bulleted-list"><li style="list-style-type:circle">Neuronal activityê°€ ì˜í–¥ì„ ë¯¸ì¹˜ë‚˜ ì•„ë‹˜ OPC ë°œë‹¬ì€ ê°œë³„ì ì¸ê°€,</li></ul><ul id="1422e869-bf9d-8146-895d-fab1e5e94821" class="bulleted-list"><li style="list-style-type:circle">myelinationì€ plastic and adpatable í•œê°€</li></ul><ul id="1422e869-bf9d-8149-82a5-cee287706b4d" class="bulleted-list"><li style="list-style-type:circle">Neural-glial interaction.</li></ul></li></ul><ul id="1422e869-bf9d-8094-87b4-ff016792977f" class="bulleted-list"><li style="list-style-type:disc">Neuroanl activityê°€ OPC proliferation, myelination ìœ ë°œ</li></ul><ul id="1422e869-bf9d-804f-8402-e3da41290cd3" class="bulleted-list"><li style="list-style-type:disc">Myelination â†’ attentoin, memory, learning ê¸°ëŠ¥ ê´€ì—¬</li></ul><ul id="1422e869-bf9d-80a4-91ba-f637aac3fbc3" class="bulleted-list"><li style="list-style-type:disc">Optic neural activity â†’ optic gliomaì—ì„œ tumor sizeë¥¼ í‚¤ìš°ê³  initiationí•˜ëŠ”ë° ì˜í–¥ì„ ë¼ì¹¨</li></ul><ul id="1422e869-bf9d-80f5-8146-f905fffaa26f" class="bulleted-list"><li style="list-style-type:disc">NLGN3 â†’ glioma growthì— driving gene, breast cancerì—ì„  ìƒê´€ì—†ì—ˆê³  gliomaì—ì„œë§Œ ì˜í–¥ë ¥ì´ ì—„ì²­ë‚¬ìŒ<ul id="1422e869-bf9d-81e6-8667-fb7eeb6ee560" class="bulleted-list"><li style="list-style-type:circle">NLGN3ëŠ” postsynaptic cellsì—ì„œì‹ í˜¸ ì „ë‹¬ ë°›ì€ ë‹¤ìŒ FAK â†’ SRC/RAS/PI3K-mTOR pathway ìê·¹í•˜ëŠ”ë° ì´ ë•Œ synapse-related genesë“¤ì´ up-expressed ë˜ëŠ” ê±° í™•ì¸</li></ul><ul id="1422e869-bf9d-81b9-9ff3-d5712db092a9" class="bulleted-list"><li style="list-style-type:circle">ê´€ë ¨ paper) <a href="https://www.nature.com/articles/s41586-019-1563-y">https://www.nature.com/articles/s41586-019-1563-y</a></li></ul></li></ul><ul id="1422e869-bf9d-807b-a6b9-e04ade97b8a9" class="bulleted-list"><li style="list-style-type:disc">Barron et al., unpublishedì—ì„œëŠ” neuron-glial ì¤‘ì—ì„œë„ GABAergic â†” Oligo â†’ glioma cells ê´€ê³„ë¥¼ ë³´ëŠ” ë“¯</li></ul><h3 id="1422e869-bf9d-8082-8e97-e5e248c6ee88" class="">QnA</h3><ul id="1422e869-bf9d-80e3-b395-e6287eb24eb4" class="bulleted-list"><li style="list-style-type:disc">Macrophage ì—­í•  ë¬¼ì–´ë³¸ ë“¯<ul id="1422e869-bf9d-8192-a824-d9fa5b4ce149" class="bulleted-list"><li style="list-style-type:circle">Tumor environmentì— ì˜í–¥ ë¼ì¹¨? preprintì—ì„œ ë‹¤ë¤˜ìœ¼ë‹ˆê¹Œ ë‚˜ì¤‘ì— ê·¸ê±° ë´ë‹¬ë¼?</li></ul></li></ul><p id="1422e869-bf9d-80df-a484-f349c019be22" class="">ì—¬ë‹´) Keystone symposiumì—ì„œ cancer neuroscience ì»¨í¼ëŸ°ìŠ¤ ê°œìµœí•˜ë‹ˆê¹Œ ë§ì´ ì‹ ì²­í•´ë‹¬ë¼ê³  í•¨ â†’ ì´ë¶„ì´ organizerì¸ ë“¯?! ì—„ì²­ë‚œ ë¶„ì´ì…¨ë‹¤â€¦!</p><h2 id="1422e869-bf9d-8065-a62c-c6901aa6b8ed" class="">3) Enhancer-AAVs enable circuit access across species and circuit selective therapies</h2><p id="1422e869-bf9d-803e-a479-d6b1be5f7262" class=""><strong><a href="https://www.vibconferences.be/speaker/boaz-levi">Boaz Levi</a></strong><strong> - </strong><em>Allen Institute for Brain Science, US</em></p><figure id="1422e869-bf9d-8072-bed0-e878461ea770" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%205.png"><img style="width:645.984375px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%205.png"/></a></figure><p id="1422e869-bf9d-80aa-b998-da8ffe05d9c5" class="">ì˜¤ëŠ˜ ì†Œê°œí•œ papers &amp; tools<div class="indented"><p id="1422e869-bf9d-8192-b9a2-f52480a49678" class="">1. <a href="https://www.biorxiv.org/content/10.1101/2024.06.10.597244v3.full">https://www.biorxiv.org/content/10.1101/2024.06.10.597244v3.full</a></p><ol type="1" id="1422e869-bf9d-8183-8532-e089cb5a7d9f" class="numbered-list" start="2"><li><a href="https://www.biorxiv.org/content/10.1101/2024.09.27.615553v1.full">https://www.biorxiv.org/content/10.1101/2024.09.27.615553v1.full</a></li></ol><ol type="1" id="1422e869-bf9d-81a1-808c-d9967e59d80a" class="numbered-list" start="3"><li><a href="https://www.biorxiv.org/content/10.1101/2024.07.30.605864v1.full">https://www.biorxiv.org/content/10.1101/2024.07.30.605864v1.full</a></li></ol><ol type="1" id="1422e869-bf9d-8143-a7e7-d6f8325a2a9d" class="numbered-list" start="4"><li><a href="https://portal.brain-map.org/genetic-tools/genetic-tools-atlas">https://portal.brain-map.org/genetic-tools/genetic-tools-atlas</a></li></ol></div></p><h3 id="1422e869-bf9d-806a-9259-e5e7cde47bea" class="">Topic 1: Cell type / Region specific enhancer-AAV targeting</h3><ul id="1422e869-bf9d-8023-a1f7-d63c40f47ca4" class="bulleted-list"><li style="list-style-type:disc"><strong>Tools to target classes (based on gene expression?)</strong><ul id="1422e869-bf9d-8089-93d8-fe6325533940" class="bulleted-list"><li style="list-style-type:circle">Enhancer-centered approach</li></ul></li></ul><ul id="1422e869-bf9d-80a2-a552-cc233b4e36f1" class="bulleted-list"><li style="list-style-type:disc">Selective transcription â†’ rely on open chromatin. Regulatory element accessibility.<ul id="1422e869-bf9d-8090-b87e-cebc6ba6e675" class="bulleted-list"><li style="list-style-type:circle">ATAC-seq. Accessibiltiy to transposable element. Open chromatin ì§€ì—­ ì°¾ëŠ”ë‹¤.</li></ul><ul id="1422e869-bf9d-809c-83ce-e275da08d95f" class="bulleted-list"><li style="list-style-type:circle">Gene expression + Epigenetic â†’ putative enhancer elements.</li></ul><ul id="1422e869-bf9d-8188-8308-e8a32cd05843" class="bulleted-list"><li style="list-style-type:circle">Collectiion of putative enhancer elements at different cell types.</li></ul><figure id="1422e869-bf9d-80e1-90fa-d8d5802191c5" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%206.png"><img style="width:617.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%206.png"/></a></figure></li></ul><ul id="1422e869-bf9d-8074-b895-c701024a99d5" class="bulleted-list"><li style="list-style-type:disc">Enhancer AAV â†’ screen for function.<figure id="1422e869-bf9d-8026-a849-d02ef787cd4c" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%207.png"><img style="width:617.984375px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%207.png"/></a></figure><ul id="1422e869-bf9d-81b3-a8cd-df30f7965198" class="bulleted-list"><li style="list-style-type:circle">Specific peak ì°¾ê³ , AAVë¡œ ì „ë‹¬, íˆ´ ì‚¬ìš©í•´ì„œ validation (ex. scRNA-seq)<ul id="1422e869-bf9d-807e-9110-d5444f9e9232" class="bulleted-list"><li style="list-style-type:square">selective expression. </li></ul></li></ul></li></ul><ul id="1422e869-bf9d-80df-b7d5-fa64adc88489" class="bulleted-list"><li style="list-style-type:disc">AAV â€”&gt; ì „ ì§€ì—­ cover ê°€ëŠ¥. Specificí•˜ê²Œ region / cell typeì„ targetí•˜ëŠ” ê²ƒë„ ê°€ëŠ¥í•¨.<figure id="1422e869-bf9d-8070-9475-f1e8b1b1ff1e" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%208.png"><img style="width:617.984375px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%208.png"/></a></figure><ul id="1422e869-bf9d-8151-9ae9-da36d67d0404" class="bulleted-list"><li style="list-style-type:circle">Cell type specific enhancer-AAV vector ì‚¬ìš© (glial cellë„ ê°€ëŠ¥)</li></ul></li></ul><ul id="1422e869-bf9d-8036-abd4-d6a420ce9ab9" class="bulleted-list"><li style="list-style-type:disc">ì–¸ì œ enhancerê°€ restrict the gene expressionì„ í•˜ëŠ”ê°€?</li></ul><ul id="1422e869-bf9d-8046-a1ee-d372ffdaf849" class="bulleted-list"><li style="list-style-type:disc">Enhancer â†’ list ì œê³µí•˜ê³ ì í•œë‹¤. ì˜¤ëŠ˜ í†¡ì—ì„œ. Collections of enhancers â†’ in review, BioRxiv ìƒíƒœì— ìˆìŒ.</li></ul><ul id="1422e869-bf9d-80e5-9f8d-c95fa3222d87" class="bulleted-list"><li style="list-style-type:disc">Enhancer-AAV â†’ ì–´ë–¤ ê²Œ íŠ¹ì • tissueì—ì„œ ë°œí˜„ë˜ê³  ì–´ë–¤ cell type ì´ë‘ ë§¤ì¹­ë˜ë‚˜â€¦ ê·¸ëŸ° ê±¸ ë³´ëŠ” ê²ƒ ê°™ìŒ. </li></ul><ul id="1422e869-bf9d-8103-9ee5-eefbfbe8a891" class="bulleted-list"><li style="list-style-type:disc">AAVë¡œ Promoterë¥¼ íƒ€ê²Ÿí•˜ëŠ” ê²ƒì€ ë§¤ìš° ì–´ë µë‹¤.</li></ul><ul id="1422e869-bf9d-8073-91a2-f4b9445c479c" class="bulleted-list"><li style="list-style-type:disc">Enhancerë“¤ì„ ì—¬ëŸ¬ê°€ì§€ë¡œ í…ŒìŠ¤íŠ¸í•˜ë©´ì„œ selective targetì„ ì°¾ê³ ìí•œë‹¤ëŠ” ê²ƒ ê°™ìŒ.</li></ul><figure id="1422e869-bf9d-80c1-8305-f35ba5a56780" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%209.png"><img style="width:645.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%209.png"/></a></figure><ul id="1422e869-bf9d-8001-a446-e44b424bb260" class="bulleted-list"><li style="list-style-type:disc">striatal enhancerëŠ” evolutionarily conserved í•¨ â†’ D1-MSN í™œì„±</li></ul><ul id="1422e869-bf9d-8089-8c98-f28fdd37e675" class="bulleted-list"><li style="list-style-type:disc"><strong>Collection of highly-validated enhancer-AAVs for the major striatal cell types.</strong></li></ul><h3 id="1422e869-bf9d-8036-a70d-dfd34b0eeefd" class="">Topic 2: Disease-context application</h3><ul id="1422e869-bf9d-804f-af58-faefeffdcd2d" class="bulleted-list"><li style="list-style-type:disc">Dravet syndrom â†’ type of epilepsy caused by SCN1A haploinsufficiency.<ul id="1422e869-bf9d-8152-ad4b-ce65b1a53703" class="bulleted-list"><li style="list-style-type:circle">Inhibitory neurons are specifically dysfunctional</li></ul><ul id="1422e869-bf9d-81f8-95ad-d5a63fbc3d65" class="bulleted-list"><li style="list-style-type:circle">ë„ˆë¬´ excitedë˜ëŠ” ê²ƒì´ íŠ¹ì§•.</li></ul></li></ul><ul id="1422e869-bf9d-80ec-81d1-efa847eb2d19" class="bulleted-list"><li style="list-style-type:disc">PVALB, SST deletion â†’ seizure and mortality</li></ul><ul id="1422e869-bf9d-803d-8620-eb3fac28e1d5" class="bulleted-list"><li style="list-style-type:disc">AAV í™œìš©ë°©ì•ˆ â†’ SCN1A gene replacement. </li></ul><ul id="1422e869-bf9d-8003-81be-fda41b43a235" class="bulleted-list"><li style="list-style-type:disc">Inhibitory neuron targetì€ ë§¤ìš° ì„±ê³µì ìœ¼ë¡œ ëìŒ. ê·¸ëŸ¬ë©´ ì´ëŸ¬í•œ therapyê°€ ì‹¤ì œë¡œ workí•˜ë‚˜?<ul id="1422e869-bf9d-81c3-b164-f3232973af52" class="bulleted-list"><li style="list-style-type:circle">Dravet mice â†’ 100% rescue. </li></ul><ul id="1422e869-bf9d-81ed-a0b2-ffc00fd6da46" class="bulleted-list"><li style="list-style-type:circle">Seizureë„ ë§ì´ ì¤„ì–´ë“¦</li></ul><ul id="1422e869-bf9d-81c9-ab2f-df5445e9cad9" class="bulleted-list"><li style="list-style-type:circle">ì´ëŸ° therapy ì ìš©í•  ë•Œ target circuitì„ ì •í™•íˆ íƒ€ê²Ÿí•˜ëŠ” ê²ƒì´ ë§¤ìš° ì¤‘ìš”í•¨. (safe ìœ„í•´ì„œë„)</li></ul></li></ul><ul id="1422e869-bf9d-8070-b2fb-ed468d14a523" class="bulleted-list"><li style="list-style-type:disc"><strong>Enhancer-AAVê°€ brain function ì—°êµ¬ì™€ neurological disorder threatment targetì„ ì—°êµ¬í•˜ëŠ”ë° ë§¤ìš° ìœ ìš©í•œ toolì´ ë  ê²ƒ</strong></li></ul><figure id="1422e869-bf9d-80cc-9436-f17130598070" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2010.png"><img style="width:645.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2010.png"/></a></figure><h3 id="1422e869-bf9d-80a5-976f-ee6888222fbe" class="">QnA.</h3><ul id="1422e869-bf9d-80fd-af62-f4a0b4ca6a13" class="bulleted-list"><li style="list-style-type:disc">Enhancer effectê°€ ì–¸ì œê¹Œì§€ ìœ ì§€ë˜ëŠ”ì§€?<ul id="1422e869-bf9d-81b9-a6a2-c00a38445377" class="bulleted-list"><li style="list-style-type:circle">1ë…„ë‚´ë¡œ ì¢€ ë‚´ë ¤ê°€ëŠ”ë° ë§ì´ëŠ” ì•„ë‹ˆê³ â€¦ enhancerë§ˆë‹¤ ë‹¤ë¥´ê¸´ í•œë° ì£¼ëª©í•´ì•¼ë§ í¬ì¸íŠ¸ì„.</li></ul></li></ul><ul id="1422e869-bf9d-8048-af9b-f5d8f3b48b51" class="bulleted-list"><li style="list-style-type:disc">Other capsid platformë„ ì‚¬ìš©í•´ë´¤ëŠ”ì§€?</li></ul><ul id="1422e869-bf9d-802f-861a-d8c1a5bf1524" class="bulleted-list"><li style="list-style-type:disc">:LentivirusëŠ” ì‚¬ìš©í•´ë´¤ëŠ”ì§€? In vitroë¡œ AAVëŠ” workí•˜ì§€ ì•Šì•˜ìŒ.<ul id="1422e869-bf9d-81a3-91fa-f5f806a2d4ca" class="bulleted-list"><li style="list-style-type:circle">agnostic to viral tools.. .ë‹¤ë¥¸ ê±°ì— ì˜í–¥ë°›ëŠ”ê²ƒê°™ì€ë°. insertion siteê°™ì€â€¦ strong enhancerì´ê³  Robustí•˜ë©´ ì˜ workí•˜ê² ì§€ë§Œâ€¦ ë‹¤ë¥¸ í”Œë«í¼ì€ ë‹¤ openì¸ê²ƒê°™ë‹¤.</li></ul></li></ul><p id="1422e869-bf9d-803b-bb9e-ce3d7e4a16d3" class="">
</p><h2 id="1422e869-bf9d-80d1-976c-ee2b7f9fa4aa" class="">4) Spatially resolved single-cell genomics &amp; cell atlas of the brain</h2><p id="1422e869-bf9d-8071-82ba-f08bb30df86f" class="">Xiaowei Zhuang, Harvard University â†’ VIZGENì´ë¼ëŠ” íšŒì‚¬ì˜ co-founderì´ê¸°ë„ í•¨.<div class="indented"><ul id="1422e869-bf9d-817d-b19b-ebecbe5d75da" class="bulleted-list"><li style="list-style-type:disc">VIzgenì´ MERFISH, MERSCOPE ê¸°ìˆ ì„ ê°œë°œ &amp; ì£¼ë ¥ìœ¼ë¡œ í•˜ëŠ” íšŒì‚¬ë‹¤</li></ul><ul id="1422e869-bf9d-81b7-9042-d9f7591ec1f3" class="bulleted-list"><li style="list-style-type:disc">ì–‘ì§ˆì˜ ë°ì´í„°ë¥¼ ë§ì´ ë§Œë“¤ì–´ë‚¼ ìˆ˜ ìˆëŠ” ì´ìœ ê°€ ìˆì—ˆë‹¤..</li></ul></div></p><ul id="1422e869-bf9d-803f-83bd-eb7377beb81c" class="bulleted-list"><li style="list-style-type:disc">Spatial â†’ Molecular / cellular architecture of the brain ì—°êµ¬ì— ì–´ë–»ê²Œ í™œìš©ë  ìˆ˜ ìˆì„ ê²ƒì¸ê°€.</li></ul><ul id="1422e869-bf9d-80ff-9fff-fd3463114851" class="bulleted-list"><li style="list-style-type:disc">MERFISH: measure many genes simultaneously. <ul id="1422e869-bf9d-80eb-8b51-e84f205355df" class="bulleted-list"><li style="list-style-type:circle">Combinatorial labeling of oligo probes</li></ul><ul id="1422e869-bf9d-8068-ae28-f40b33e3bccd" class="bulleted-list"><li style="list-style-type:circle">Scalability. ëª‡ë²ˆ round ì•ˆëŒì•„ë„ ì—„ì²­ ë§ì€ ìœ ì „ìë“¤ ì¸¡ì • ê°€ëŠ¥í•˜ë‹¤. </li></ul><ul id="1422e869-bf9d-8002-af3b-e4473b0f7881" class="bulleted-list"><li style="list-style-type:circle">Error detection &amp; correction â†’ High accuracy.</li></ul></li></ul><ul id="1422e869-bf9d-8039-8fdc-fc0c4f3ab019" class="bulleted-list"><li style="list-style-type:disc">10ë…„ ì „ì—ë„ 10,050 ìœ ì „ìë¥¼ ì¸¡ì •ì´ ê°€ëŠ¥í–ˆë‹¤.</li></ul><ul id="1422e869-bf9d-809c-b30c-e9982da2bfa5" class="bulleted-list"><li style="list-style-type:disc"><strong>Spatial distribution of RNAs inside the cells.</strong></li></ul><ul id="1422e869-bf9d-80ab-a178-e5badef9bc4a" class="bulleted-list"><li style="list-style-type:disc"><strong>MERFISH â†’ 3D genome organization</strong>, single-cell epigenomicsë¡œë„ í™•ì¥.<figure id="1422e869-bf9d-8002-b3f6-c56e63de156b" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2011.png"><img style="width:586.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2011.png"/></a></figure><ul id="1422e869-bf9d-80dd-81bd-c121f5d3d7dc" class="bulleted-list"><li style="list-style-type:circle">Localize chromatin loci.</li></ul><ul id="1422e869-bf9d-80ba-a5b4-dc388f7139a2" class="bulleted-list"><li style="list-style-type:circle">Multimodal. </li></ul><ul id="1422e869-bf9d-80c6-86e2-f5b784d99411" class="bulleted-list"><li style="list-style-type:circle">Epigenetic â†’ gene regulationì— ì¤‘ìš”. CUT&amp;TAG + MERFISH.</li></ul></li></ul><ul id="1422e869-bf9d-8070-8fa5-f615ddcbe99d" class="bulleted-list"><li style="list-style-type:disc">Mouse brain atlas based on spatial techniques.<ul id="1422e869-bf9d-8127-9605-e1e2519d9dd3" class="bulleted-list"><li style="list-style-type:circle">Zhang et al., Nature (2024)</li></ul><ul id="1422e869-bf9d-8018-a5f4-ecb6ad28482d" class="bulleted-list"><li style="list-style-type:circle">ë°ì´í„°ë¥¼ ê³„ì† shareí•˜ê³ , collaborateí•˜ë©´ì„œ ì „ì²´ brainì„ ì•„ìš°ë¥´ê³ ì ë…¸ë ¥í•œë‹¤.</li></ul></li></ul><ul id="1422e869-bf9d-8034-b2d5-fe2f8fe53eb7" class="bulleted-list"><li style="list-style-type:disc">DNA MERFISH â†’ 3D genomeê¹Œì§€.<ul id="1422e869-bf9d-802e-a7bd-d55f0f6435ae" class="bulleted-list"><li style="list-style-type:circle">Wide spectrum of differences in 3D-genome organization in different cell types. </li></ul><ul id="1422e869-bf9d-808d-b692-e3d3c4c0d92c" class="bulleted-list"><li style="list-style-type:circle">MeCP2 â†’ rett syndrome. methylated DNA binding protein. </li></ul><figure id="1422e869-bf9d-8080-9733-ce2dc81e8617" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2012.png"><img style="width:586.9921875px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2012.png"/></a></figure></li></ul><ul id="1422e869-bf9d-802d-aa2d-fab94453c42f" class="bulleted-list"><li style="list-style-type:disc">MERFISH ë°ì´í„°ë¥¼ scRNA-seqê³¼ integrate ê°€ëŠ¥ â†’ ì§€ê¸ˆ ë³´ë‹ˆê¹Œ batchë„ ê±°ì˜ ì—†ê³  ìˆ˜ìœ¨ë„ ì¢‹ì€ ê²ƒ ê°™ë‹¤. scRNA-seqì´ë‘ cell ì–‘ ê±°ì˜ ë¹„ìŠ·í•´ë³´ì„. ìš°ë¦¬ë„ atlasí•  ë•Œ MERFISH í™•ë³´í•´ì„œ ê°™ì´ í™œìš©í•´ë³¼ ìˆ˜ ìˆì„ê²ƒê°™ìŒ.<ul id="1422e869-bf9d-81b2-9888-c7f745d600bd" class="bulleted-list"><li style="list-style-type:circle">Visiumë³´ë‹¤ MERFISHê°€ resolutionì´ í›¨ë°° ì¢‹ì•„ì„œ ì“°ë©´ ì§„ì§œë¡œ ì¢‹ê² ë‹¤..</li></ul><ul id="1422e869-bf9d-805b-a404-d5ce416ec032" class="bulleted-list"><li style="list-style-type:circle">de novo annotationì„ ì•ˆí•˜ë ¤ê³  í•¨. communityì˜ ë°©ì‹ì„ ë”°ë¼ê°€ê³ ì í•¨. ë”°ë¼ì„œ Label transfer ë°©ì‹ì„ ì‚¬ìš©í•˜ì˜€ìŒ.</li></ul></li></ul><ul id="1422e869-bf9d-80cb-baec-c021f1564d7d" class="bulleted-list"><li style="list-style-type:disc">Cell-cell interactions: from somtic contatc, paracrine singaling or short-range interactions<ul id="1422e869-bf9d-81c7-ae80-eb58b556467b" class="bulleted-list"><li style="list-style-type:circle">soma contact, proximity ê¸°ë°˜ìœ¼ë¡œ random chanceë³´ë‹¤ ë†’ì€ ë¹ˆë„ë¡œ ë‚˜íƒ€ë‚˜ëŠ” interaction ì¶”ì •</li></ul></li></ul><ul id="1422e869-bf9d-8002-aebc-dbef1ee2fca2" class="bulleted-list"><li style="list-style-type:disc">Human cortexê°€ mouseì™€ ë¹„êµí•´ì„œ neuron â†” glial interactionì´ í›¨ì”¬ ë§ì´ ë‚˜íƒ€ë‚¨<ul id="1422e869-bf9d-8182-b848-e15ca8d0572f" class="bulleted-list"><li style="list-style-type:circle">íŠ¹íˆ, oligodendrocytes â†” inhibitory neuron ê°„ interactionì´ ë‘ë“œëŸ¬ì§</li></ul><ul id="1422e869-bf9d-8165-9a52-c714d309b437" class="bulleted-list"><li style="list-style-type:circle">Oligodendrocytes energy â†’ neuron ì „ë‹¬</li></ul><ul id="1422e869-bf9d-81b5-b205-d8370ee44cd3" class="bulleted-list"><li style="list-style-type:circle">Microglia â†” Excitatory neuron ê°„ interactionë„ human cortexì—ì„œ ëˆˆì— ë„ê²Œ enrichment ìˆìŒ (Fang et al, Science, 2023)</li></ul></li></ul><h3 id="1422e869-bf9d-803f-9120-c3fe3ae5429e" class="">Cell type specific 3D genome genome organization (<a href="https://www.biorxiv.org/content/10.1101/2023.12.04.570024v1">Liu et al., bioRxiv 2023</a>)</h3><ul id="1422e869-bf9d-80a0-899b-f6d4c78b4738" class="bulleted-list"><li style="list-style-type:disc">RNA- and DNA MERFISH í†µí•©</li></ul><ul id="1422e869-bf9d-807d-b7f3-d60e88c94c96" class="bulleted-list"><li style="list-style-type:disc">MeCP2 â†’ active-inative chromatin segreation and regulate transcirption in a nuclear-radial-position and cell-type dependent manner<ul id="1422e869-bf9d-8141-986a-f1796dad6eb4" class="bulleted-list"><li style="list-style-type:circle">Ratt syndrome</li></ul><ul id="1422e869-bf9d-8157-9fb0-e798acbd33fd" class="bulleted-list"><li style="list-style-type:circle">MeCP2 â†’ ì–´ë–»ê²Œ ë‹¤ë¥¸ ìœ ì „ìë“¤ì„ ì´ ìœ ì „ìê°€ down regulation ì‹œí‚¤ëŠ”ì§€ ì˜ ëª¨ë¦„</li></ul></li></ul><ul id="1422e869-bf9d-80e1-921d-c382a0c7274b" class="bulleted-list"><li style="list-style-type:disc">MeCP2 KO â†’ L2/3 ITì—ì„œ inactive ìƒíƒœê°€ ëŠ˜ì–´ë‚¬ê³ , ê° cell type ë³„ë¡œ radial positionì„ neuclar interior â†’ neuclear peripheryì—ì„œ ì–´ë–»ê²Œ ë³€í™”í•˜ëŠ”ì§€ ë´¤ëŠ”ë° interiorë³´ë‹¤ neuclear periphery ìª½ì— ë” ë§ì´ ìœ„ì¹˜í•˜ê²Œ ë¨ <p id="1422e869-bf9d-8151-a68a-cf1e6a9f2a63" class="">â†’ 3D êµ¬ì¡°ë¥¼ ì ‘ì§€ ì•Šê³  í¼ì ¸ ìˆë‹¤ëŠ” ê±°ë‹ˆê¹Œ (unfolded ìƒíƒœ) inactivation ìƒíƒœì¸ ê²ƒì´ ë” ë§ì•„ì¡Œë‹¤ë¼ëŠ” ì˜ë¯¸?</p></li></ul><ul id="1422e869-bf9d-807a-b5a9-ecae43ea03f9" class="bulleted-list"><li style="list-style-type:disc">MERFISH + genetic variation â†’ Genetic variation, protein variationì„ ì¤€ ë‹¤ìŒ MERFISH ê´€ì°°<ul id="1422e869-bf9d-8110-bf9e-c9aac96b0bb3" class="bulleted-list"><li style="list-style-type:circle">Genotype â†” Phenotype</li></ul><ul id="1422e869-bf9d-817b-be21-ffc87999c211" class="bulleted-list"><li style="list-style-type:circle">RNA sequencingê³¼ imagingì„ ê°™ì´</li></ul></li></ul><ul id="1422e869-bf9d-8059-99ae-e8304ee3e10a" class="bulleted-list"><li style="list-style-type:disc">Perturbations. CRISPR. í•µì‹¬ ê°œë….</li></ul><ul id="1422e869-bf9d-801d-8e79-cb22e0e355fe" class="bulleted-list"><li style="list-style-type:disc">Genome-wide perturbation in single sample. See the phenotype. Lot of predictions of molecular mechanisms. Lots of phenotypes â†’ imagingì„ ë”í•˜ê¸°. </li></ul><ul id="1422e869-bf9d-8027-8a1b-d3e7f1f1c7c7" class="bulleted-list"><li style="list-style-type:disc"><strong>Variety of interesting phenotypes â†’ which particular guide RNA did this particular phenotype received?</strong><ul id="1422e869-bf9d-80b2-b2fe-e0ebcbe69a1f" class="bulleted-list"><li style="list-style-type:circle"><strong>MERFISH â†’ Genetic perturbationì„ read out. </strong><figure id="1422e869-bf9d-804f-8a66-f9c73b1a1690" class="image"><a href="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2013.png"><img style="width:558.984375px" src="Session%203%20From%20Atlassing%20to%20therapy%2013a2e869bf9d801b8f90fc1e987c46e7/image%2013.png"/></a></figure></li></ul></li></ul><h3 id="1422e869-bf9d-80cb-bef7-c6e359a4293d" class="">QnA</h3><ul id="1422e869-bf9d-8073-86a1-eef1efeaac48" class="bulleted-list"><li style="list-style-type:disc">3D genomeì—ì„œ cell type prediction<ul id="1422e869-bf9d-8190-9bb8-cfd908a696b9" class="bulleted-list"><li style="list-style-type:circle">chromatin accessibility</li></ul><ul id="1422e869-bf9d-814d-970e-f741259e9224" class="bulleted-list"><li style="list-style-type:circle">AIê°€ ë‹µì¸ê°€</li></ul></li></ul><ul id="1422e869-bf9d-80ed-87c6-c5054903bea3" class="bulleted-list"><li style="list-style-type:disc">MeCP2 functionì´ developmentì— ë”°ë¼ ì–´ë–»ê²Œ ë‹¬ë¼ì§€ëŠ”ì§€ì— ëŒ€í•´ ë¬¼ì–´ë³¸ ë“¯?</li></ul><h2 id="1422e869-bf9d-8070-99ab-c5c4af33a4db" class="">5) Modeling and repairing the human brain with stem cells</h2><p id="1422e869-bf9d-808d-b9a3-e90de4c48b0f" class=""><strong><a href="https://www.vibconferences.be/speaker/agnete-kirkeby">Agnete Kirkeby</a></strong><strong>, </strong><em>Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), University of Copenhagen, DK</em></p><p id="1422e869-bf9d-8089-9190-e2afb4a9165d" class="">ì—¬ë‹´) ê±°ì˜ ëª¨ë“  ì—°ì‚¬ë¶„ë“¤ì´ ë°œí‘œí•˜ëŠ” ê²°ê³¼ë§ˆë‹¤ í•´ë‹¹ ì—°êµ¬ë¥¼ í•œ ì‚¬ëŒë“¤ì„ talented people/handsome people~ í•˜ë©´ì„œ í•œ ëª…ì”© ë‹¤ì •í•˜ê²Œ ì†Œê°œí•˜ëŠ” ê²ƒì´ ì¢‹ê²Œ ëŠê»´ì§! ì• ì •ì´ ëŠê»´ì§„ë‹¤ë„ê¹Œ</p><ul id="1422e869-bf9d-8063-ad89-d6c6649f433c" class="bulleted-list"><li style="list-style-type:disc">MiSTR models</li></ul><ul id="1422e869-bf9d-80bd-bbb0-ca4093c043e3" class="bulleted-list"><li style="list-style-type:disc">ê³¼ê±°ì—ëŠ” neuralisation ì‹¤í—˜í•  ë•Œ neuralisation â†’ patterning ìˆœìœ¼ë¡œ ê³¼ì •ì´ ì§„í–‰ëëŠ”ë°, ìƒˆë¡œìš´ protocolì€ neuralisation&amp;patterningì„ ë™ì‹œì— í•´ì„œ ë³¼ ìˆ˜ ìˆìŒ</li></ul><h3 id="1422e869-bf9d-80ba-a491-fbd929743b17" class="">Developing cell therapy for Parkinsonâ€™s disease</h3><ul id="1422e869-bf9d-80bf-b992-dd2823de495b" class="bulleted-list"><li style="list-style-type:disc">Substantia nigraì˜ dopamine neuronsì´ ë¬¸ì œ â†’ dopamine neuron replacementê°€ therapy ë„ì›€ë  ê²ƒ</li></ul><ul id="1422e869-bf9d-80b4-a173-ebca0c50d5d2" class="bulleted-list"><li style="list-style-type:disc">Mini pigë¥¼ ê°€ì§€ê³  dopamine neuron ê¸°ëŠ¥ì„ validation í•¨ (ì˜¤ëŠ˜ë„ ë¶ˆìŒí•œ pig..)<ul id="1422e869-bf9d-81eb-8522-c8d18cec8f15" class="bulleted-list"><li style="list-style-type:circle">DA neuronì„ ì‹¬ì—ˆë”ë‹ˆ dopamine ë¶„ë¹„ ëŠ˜ì–´ë‚¨</li></ul></li></ul><ul id="1422e869-bf9d-8084-b9b3-f599a284c866" class="bulleted-list"><li style="list-style-type:disc">PD+L-DOPA â†’ non-DA neuronì´ ë”í•´ì ¸ì„œ neurotransmitter ë¶„ë¹„ ê³¼í•´ì§€ë©´ involuntary movement ì•¼ê¸°<ul id="1422e869-bf9d-814a-91b5-e6293de69486" class="bulleted-list"><li style="list-style-type:circle">L-DOPA ìœ ë„ ì¤„ì˜€ë”ë‹ˆ í˜¸ì „ë¨</li></ul><ul id="1422e869-bf9d-81fb-9ba8-ee0d15e6d04a" class="bulleted-list"><li style="list-style-type:circle">Dopamine neuron ì´ì‹ì´ ê³¼í•œ dopamine ì¬í¡ìˆ˜ë„ ë•ëŠ”ë‹¤ëŠ” ê±´ê°€</li></ul></li></ul><ul id="1422e869-bf9d-8010-a5c4-c448da8ad913" class="bulleted-list"><li style="list-style-type:disc">Stem cell, cell transplantation ì¹˜ë£Œë¼ëŠ” ê°œë…ì´ ì‹ ê¸°í•˜êµ¬ë§Œ..</li></ul><h3 id="1422e869-bf9d-8089-a83f-f4461f11805f" class="">Where are we now with hPSC-based trials?</h3><ul id="1422e869-bf9d-8023-9e7a-f2671191bfef" class="bulleted-list"><li style="list-style-type:disc">hPSC trialsëŠ” ë§¤ë…„ ì¦ê°€í•˜ê³  ìˆìŒ<ul id="1422e869-bf9d-8141-b867-e60d59966267" class="bulleted-list"><li style="list-style-type:circle">CNSëŠ” 16% ì •ë„</li></ul><ul id="1422e869-bf9d-8124-b524-f00fffd56b16" class="bulleted-list"><li style="list-style-type:circle">24ê°œ ì‹œë„ ì¤‘ì—ì„œë„ ì ˆë°˜ì€ Parkinsonâ€™s diseaseì—ì„œ DA íƒ€ê²Ÿí•˜ëŠ” ê±°</li></ul><ul id="1422e869-bf9d-8190-9f0f-f83837bc3a1a" class="bulleted-list"><li style="list-style-type:circle">ê±°ì˜ ëŒ€ë¶€ë¶„ CNSì—ì„œëŠ” neurodegenerative disordersë‚˜ stroke ê°™ì€ ì§ˆí™˜ì—ì„œ ì‹œë„ë˜ê³  ìˆìŒ<ul id="1422e869-bf9d-81a1-b760-d9cf22a705c7" class="bulleted-list"><li style="list-style-type:square">Neurodevelopmental, psychiatric ë¶„ì•¼ëŠ” ì•„ì§ X â†’ targetì´ ëª…í™•í•˜ì§€ ì•Šì•„ì„œ ì¼ê¹Œ</li></ul></li></ul></li></ul><ul id="1422e869-bf9d-809a-8085-e0f73cab6c0f" class="bulleted-list"><li style="list-style-type:disc">Epilepsyì—ì„œ interneuron transplantationí•˜ëŠ” ì—°êµ¬ ì§„í–‰ ì¤‘<ul id="1422e869-bf9d-8118-990f-df8c310c5db5" class="bulleted-list"><li style="list-style-type:circle">Seizure ê°ì†Œ íš¨ê³¼ ìˆì—ˆìŒ</li></ul></li></ul><ul id="1422e869-bf9d-8022-8804-dc7b059147ee" class="bulleted-list"><li style="list-style-type:disc">Whatâ€™s next?<ul id="1422e869-bf9d-8145-becb-c996b28c01ec" class="bulleted-list"><li style="list-style-type:circle">Basal forebrain cholinergic neuron â†’ future target</li></ul><ul id="1422e869-bf9d-81a3-9755-fec780746d78" class="bulleted-list"><li style="list-style-type:circle">dementia with Lewy bodies (DLB), PD with dementia (PDD) ì¹˜ë£Œì— íš¨ê³¼ì ì¼ ê²ƒìœ¼ë¡œ ê¸°ëŒ€</li></ul></li></ul><h3 id="1422e869-bf9d-808a-97d1-db5f3fe72e9c" class="">QnA</h3><h2 id="1422e869-bf9d-805c-8fef-e1c02b017fd2" class="">Selected poster: TREM2-dependence of Microglial Activation in Alzheimer&#x27;s Disease</h2><p id="1422e869-bf9d-8043-bc2c-f70cf2c9d377" class=""><strong>Maggie Crow - </strong><em>Genentech, Inc., US</em></p><ul id="1422e869-bf9d-8092-a421-f7a816519d84" class="bulleted-list"><li style="list-style-type:disc">AD genetics â†’ microgliaê°€ ì¤‘ìš”í•˜ë‹¤</li></ul></div></article><span class="sans" style="font-size:14px;padding-top:2em"></span></body></html>